A Pilot Trial of Using Pre-Transplant Risk Stratification and Prophylactic Defibrotide to Prevent Serious Thrombotic Microangiopathy in High-Risk Hematopoietic Stem Cell Transplant Patients
Phase of Trial: Phase II
Latest Information Update: 09 May 2018
At a glance
- Drugs Defibrotide (Primary)
- Indications Thrombosis
- Focus Adverse reactions; Therapeutic Use
- 31 Aug 2018 Biomarkers information updated
- 01 May 2018 Status changed from not yet recruiting to recruiting.
- 05 Jan 2018 Planned initiation date changed from 1 Jan 2018 to 1 Mar 2018.